Berkeley Capital Partners’s bluebird bio BLUE Stock Holding History

Berkeley Capital Partners’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-154	Closed	-$339K	–	117
2018 Q1	$339K	Sell	154 -20	-11%	-$50.9K	0.2%	95
2017 Q4	$401K	Sell	174 -13	-7%	-$26.4K	0.26%	88
2017 Q3	$333K	Sell	187 -16	-8%	-$22.4K	0.22%	99
2017 Q2	$276K	Sell	203 -36	-15%	-$43.4K	0.19%	97
2017 Q1	$282K	Buy	+239	New	+$244K	0.19%	100
2016 Q4	–	Sell	-282	Closed	-$247K	–	112
2016 Q3	$247K	Buy	+282	New	+$204K	0.18%	95

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Berkeley Capital Partners's BLUE Position: Q2 2018 in Review

Berkeley Capital Partners sold out of bluebird bio (BLUE) in Q2 2018, closing a stake of 154 shares — an estimated $339K sold.

Berkeley Capital Partners first reported a position in BLUE in Q3 2016 and held it in 6 quarters. The position peaked at $401K in Q4 2017. 307 funds tracked by Wall St. Rank hold BLUE as of Q2 2018.

Berkeley Capital Partners reported no remaining bluebird bio position as of Q2 2018 after selling out during the quarter.
Berkeley Capital Partners sold 154 bluebird bio shares in Q2 2018, an estimated $339K.
Berkeley Capital Partners first reported a position in bluebird bio in Q3 2016 and held it in 6 quarters.
Berkeley Capital Partners's bluebird bio position peaked at $401K in Q4 2017.
307 funds tracked by Wall St. Rank held bluebird bio as of Q2 2018.

Based on Berkeley Capital Partners's 13F filing for Q2 2018, filed 7 Aug 2018.